A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial. Issue 7 (6th June 2020)

Record Type:: Journal Article
Title:: A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial. Issue 7 (6th June 2020)
Main Title:: A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial
Authors:: Grosicki, Sebastian
Lech-Maranda, Ewa
Govind Babu, Kanakasetty
Rybka, Justyna
Litvinskaya, Elena
Loscertales, Javier
Kriachok, Iryna
Kłoczko, Janusz
Rekhtman, Grygoriy
Homenda, Wojciech
Blonski, Jerzy
Stefanelli, Tommaso
Vincent, Ghislaine
Banerjee, Hiya
Robak, Tadeusz
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 61:Issue 7(2020)
Journal:: Leukemia & lymphoma
Issue:: Volume 61:Issue 7(2020)
Issue Display:: Volume 61, Issue 7 (2020)
Year:: 2020
Volume:: 61
Issue:: 7
Issue Sort Value:: 2020-0061-0007-0000
Page Start:: 1748
Page End:: 1751
Publication Date:: 2020-06-06
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2020.1732960 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 13838.xml